Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2012
08/21/2012US8247603 Deuterated catecholamine derivatives and medicaments comprising said compounds
08/21/2012US8247562 Benzamide derivatives useful as histone deacetylase inhibitors
08/21/2012US8247432 Tripeptidyl peptidase inhibitors
08/21/2012US8247424 Water soluble groups on ring A; antitumor antibiotics; 1-Desoxy-5-C-[(8R)-4',9,9'-trihydroxy-6'-methoxy-1,1',3',5',8'-pentaoxo-1,1',2,3',5',6,7,8'-octahydrospiro[cyclopenta[g]isoquinoline-8,2'-cyclopenta[b]-naphthalene]-3-yl]pentitol; topoisomerase inhibitors; cyclodextrin inclusions; stereoisomers
08/21/2012US8247409 Thieno-[2,3-d]pyrimidine and thieno-pyridazine compounds and methods of use
08/21/2012US8246987 Controlled release composition and method of producing the same
08/21/2012US8246982 Pressure-sensitive adhesives based on ethylene-vinyl acetate copolymers and adhesive resins, for medical application purposes
08/21/2012CA2566215C Cyclohexyl-1,4-diamines substituted by acid derivatives
08/21/2012CA2543793C Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pain
08/21/2012CA2542442C Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an acetylcholinesterase inhibitor
08/21/2012CA2529179C Recombinant adeno-associated virus vector for treatment of alzheimer disease
08/21/2012CA2520892C Chromenoneindoles
08/21/2012CA2511021C Substituted benzodioxepines
08/21/2012CA2497351C Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same
08/21/2012CA2473886C Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
08/21/2012CA2469490C Method of preparing delta-9 tetrahydrocannabinol
08/21/2012CA2469076C Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses
08/21/2012CA2434388C Activated charcoal based composition and method for reducing hangover symptoms associated with the consumption of alcohol containing beverages
08/21/2012CA2371723C Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
08/21/2012CA2348545C A complex of a chaperone with .beta.-amyloid and methods employing this complex
08/16/2012WO2012109464A2 Modified peptide that reduces pain in peripheral neuropathy
08/16/2012WO2012109445A1 Hybrid opioid compounds and compositions
08/16/2012WO2012109373A2 Treatment of osteoarthritis and pain
08/16/2012WO2012109280A2 Apoe immunotherapy
08/16/2012WO2012109165A1 5-amino-oxazepine and 5-amino-thiazepane compounds as beta-secretase antagonists and methods of use
08/16/2012WO2012109052A1 Polymer-carbohydrate-lipid conjugates
08/16/2012WO2012109011A1 SUBSTITUTED [(5H-PYRROLO[2,1-c] [1,4]BENZODIAZEPIN-11-YL)PIPERAZIN-1-YL]-2,2-DIMETHYLPROPANOIC ACID COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS
08/16/2012WO2012108548A1 TRANSFORMANT HAVING Gm1 GENE, GPCR GENE, AND CRMP2 GENE INTRODUCED THEREIN
08/16/2012WO2012108490A1 Isoquinoline amide derivative
08/16/2012WO2012108478A1 Monocyclic compound
08/16/2012WO2012107735A2 Treatment of bipolar disorder
08/16/2012WO2012107708A1 Administration regime for nitrocatechols
08/16/2012WO2012107706A1 Phenothiazine diaminium salts and their use
08/16/2012WO2012107673A1 Use of creatine kinase for preventing or treating addiction to opiates
08/16/2012WO2012107371A1 N-[3-(5-amino-3,3a,7,7a-tetrahydro-1h-2,4-dioxa-6-aza-inden-7-yl)-phenyl]-amides as bace1 and/or bace2 inhibitors
08/16/2012WO2012107153A1 Amino statin derivativesfor the treatment of arthrosis
08/16/2012WO2012088124A3 Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof
08/16/2012WO2012087047A3 Percutaneous absorption preparation containing rivastigmine
08/16/2012WO2012079721A8 Terpenoid spiro ketal compounds with lxr agonists activity, their use and formulations with them
08/16/2012WO2012072977A3 Formulations comprising methylthionium chloride
08/16/2012WO2012071414A3 Quinoxaline compounds and uses thereof
08/16/2012WO2012068038A3 Caffeic acid derivatives and their use in improving neuronal cell viability
08/16/2012WO2012061828A3 Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord
08/16/2012WO2012028965A3 Combination of semax and choline alfoscerate with antihypoxic neuroprotective, and antiαμνesic action and with ability to improve physical efficiency
08/16/2012WO2011105099A8 Compound containing a novel 4-alkoxypyrimidine formation and medicine containing same
08/16/2012US20120209050 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
08/16/2012US20120208889 Class- and isoform-specific hdac inhibitors and uses thereof
08/16/2012US20120208876 Amino acid derivatives for the treatment of neuropathic pain
08/16/2012US20120208847 Diagnostic and Therapeutic Alkyl Piperidine/Piperazine Compounds and Process
08/16/2012US20120208843 Method of Using GPR35 to Identify Metabolic-Stabilizing Compounds
08/16/2012US20120208841 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
08/16/2012US20120208835 Method and dosage regimens for eliminating a chemical substance in blood
08/16/2012US20120208831 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
08/16/2012US20120208830 Anhydrous Crystalline Forms of N-[1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-yl-amino)-1H-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide
08/16/2012US20120208821 Alpha adrenergic receptor modulators
08/16/2012US20120208820 Diazabicyclic central nervous system active agents
08/16/2012US20120208818 Compounds useful as antagonists of ccr2
08/16/2012US20120208812 DISUBSTITUTED OCTAHYDROPYRROLO[3,4-c]PYRROLES AS OREXIN RECEPTOR MODULATORS
08/16/2012US20120208808 Pyrazolopyrimidine derivatives
08/16/2012US20120208806 Hsp90 Inhibitors
08/16/2012US20120208805 Triazolium salts as par1 inhibitors, production thereof, and use as medicaments
08/16/2012US20120208804 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
08/16/2012US20120208803 Pyrrolidine derivatives as nk2 receptor antagonists
08/16/2012US20120208797 Pyrimidone derivatives
08/16/2012US20120208796 Heterocyclic derivatives
08/16/2012US20120208795 Compositions and methods for the treatment of addiction and other neuropsychiatric disorders
08/16/2012US20120208793 Thieno- and furo-pyrimidine modulators of the histamine h4 receptor
08/16/2012US20120208790 Ion channel modulators and methods of use
08/16/2012US20120208785 Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses
08/16/2012US20120208784 Substituted propane phosphinic acid derivatives
08/16/2012US20120208783 Medicine, Food And Drink Or Feed Containing Sphingomyelin
08/16/2012US20120208777 Diosmetin compounds, a process for their preparation and pharmaceutical compositions containing them
08/16/2012US20120208773 Pharmaceutical compositions with tetrabenazine
08/16/2012US20120208766 Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healing
08/16/2012US20120208765 Modified agrin-fragment capable of restoring muscle strength for use as a medicament
08/16/2012US20120208764 Method and compositions for treating stroke with fever
08/16/2012US20120208763 Nap alpha-aminoisobutyric acid analog with neuroprotective activity
08/16/2012US20120208752 Cell proliferation-promoting peptide and use thereof
08/16/2012US20120208751 Methods for Regulating Neurotransmitter Systems by Inducing Counteradaptations
08/16/2012US20120208747 Novel peptide for augmenting and expression of bdnf and pharmaceutical composition for prevention and treatment of neurodegenerative diseases including alzheimer's disease or parkinson's disease, comprising the same
08/16/2012US20120208743 Use of gelsolin to diagnose and treat inflammatory diseases
08/16/2012US20120207845 Pharmaceutical composition of nanoparticles
08/16/2012US20120207825 Pharmaceutical compositions for reducing alcohol-induced dose dumping
08/16/2012US20120207824 Orally effective methylphenidate extended release powder and aqueous suspension product
08/16/2012US20120207820 Composition for treatment of multiple sclerosis
08/16/2012US20120207816 Transdermally Absorbable Donepezil-Containing Preparation
08/16/2012US20120207797 Dosage forms for tamper prone therapeutic agents
08/16/2012US20120207792 Injectable filler for podiatric and orthopedic uses
08/16/2012US20120207789 Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healing
08/16/2012US20120207773 Materials and methods for the development of an antigen-specific immune non-responsiveness state
08/16/2012US20120207766 Intracellular toll-like receptors pathways and axonal degeneration
08/16/2012US20120207752 Methods for modulating il-33 activity
08/16/2012US20120207749 Dosing regimen
08/16/2012US20120207745 Composition to Induce Specific Immune Tolerance
08/16/2012US20120207732 Compositions and methods for promoting neuronal outgrowth
08/16/2012US20120207725 Mesenchymal stem cell incorporating a nucleotide sequence coding tgfb, and uses thereof
08/16/2012US20120207724 Compositions for Improving Migration Potential of Stem Cells
08/16/2012US20120207713 Probiotic bifidobacterium strains
08/16/2012US20120207681 Chemical compositions to detect and treat amyloid in a patients brain and retina
08/16/2012US20120207679 Novel Heteroaryl Substituted Benzothiazoles
1 ... 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 ... 1833